Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.79.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 4 comparable quarters.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-68.10
EARNINGS PER SHARE (EPS) AVG 3Y
-34.05
EARNINGS PER SHARE (EPS) AVG 5Y
-22.70
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Polyrizon Ltd.
Market Cap
$10.37M
Earnings Per Share (EPS)
N/A
TTM Avg
-68.10
3Y Avg
-34.05
5Y Avg
-22.70
Market Cap
$10.37M
Earnings Per Share (EPS)
-1.92
TTM Avg
-10.95
3Y Avg
-6.49
5Y Avg
-5.26
Market Cap
$10.26M
Earnings Per Share (EPS)
-16.82
TTM Avg
-28.56
3Y Avg
-28.65
5Y Avg
-34.30
Market Cap
$10.51M
Earnings Per Share (EPS)
-2.79
TTM Avg
-24.53
3Y Avg
-24.53
5Y Avg
-26.36
Market Cap
$10.41M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.21
3Y Avg
-0.25
5Y Avg
-0.25
Market Cap
$10.11M
Earnings Per Share (EPS)
-56.74
TTM Avg
-13.76
3Y Avg
-493.08
5Y Avg
-1128.94
Market Cap
$10.56M
Earnings Per Share (EPS)
-1.64
TTM Avg
-2.15
3Y Avg
-4.34
5Y Avg
-5.45
Market Cap
$10.59M
Earnings Per Share (EPS)
-1.77
TTM Avg
-11.49
3Y Avg
-12.47
5Y Avg
-11.51
Market Cap
$10.59M
Earnings Per Share (EPS)
-2.45
TTM Avg
-3.00
3Y Avg
-4.04
5Y Avg
-6.77
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Polyrizon Ltd. (PLRZ) | $10.37M | N/A | -68.10 | -34.05 | -22.70 |
| Satellos Bioscience Inc. (MSLE)vs › | $10.37M | -1.92 | -10.95 | -6.49 | -5.26 |
| Lifeward Ltd. (LFWD)vs › | $10.26M | -16.82 | -28.56 | -28.65 | -34.30 |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.51M | -2.79 | -24.53 | -24.53 | -26.36 |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.41M | N/A | -0.21 | -0.25 | -0.25 |
| Valion Bio, Inc. (VBIO)vs › | $10.11M | -56.74 | -13.76 | -493.08 | -1128.94 |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.56M | -1.64 | -2.15 | -4.34 | -5.45 |
| Senti Biosciences, Inc. (SNTI)vs › | $10.59M | -1.77 | -11.49 | -12.47 | -11.51 |
| Pluri Inc. (PLUR)vs › | $10.59M | -2.45 | -3.00 | -4.04 | -6.77 |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.10M | -1.62 | -1.32 | -0.82 | -0.71 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -2.07 |
| 2024-12-31 | -134.14 |
| 2023-12-31 | 0.00 |
| 2022-12-31 | 0.00 |
| 2021-12-31 | 0.00 |
| 2020-12-31 | 0.00 |
